| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944893 | Journal of Infection and Chemotherapy | 2018 | 5 Pages |
Abstract
During the 2016-2017 influenza season in Mainland China the majority tested viruses were susceptible to oseltamivir and zanamivir. Hence, NAIs remain the recommended antiviral for treatment and prophylaxis of influenza virus infections.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Weijuan Huang, Yanhui Cheng, Xiyan Li, Minju Tan, Hejiang Wei, Xiang Zhao, Ning Xiao, Jie Dong, Dayan Wang,